The 6-7% Yielder Wall Street Keeps Calling a Value Trap

A mega-cap telecom is throwing off a 6-7% yield while trading at a significant premium to fair value. The Street has written it off as a value trap for three years running. But with a major acquisition now closed, a fiber buildout accelerating, and rate cuts back on the table, the setup looks tight.

Three Dividend Hikes That Got Lost in the Noise This Week

The Wide-Moat Snack Giant That Just Handed You an 8% Discount

A wide-moat staples giant just dropped 8% in one session. The yield finally crossed an interesting line.

The Monthly-Paying Healthcare REIT With a Demographic Wave at Its Back

A monthly-paying healthcare REIT is sitting on a demographic wave Wall Street hasn't fully priced in. Here's the setup. A 6%+ monthly yield. Below Morningstar's fair value. Senior housing tailwind still building. The market only just started paying attention.

Penske Just Stacked Its 22nd Straight Quarterly Hike

A few names pushed payouts higher this week. Nothing flashy. Just the kind of compounders you want anchoring the income side of the book.

The 27% Yield That Comes With A Warning Label

A huge payout grabs attention, but dilution risk makes this a high-stakes income trade.

The Next Banking Battleground May Not Be Branches or Rates

The Income Story Hiding Behind a Changing Financial Business

A growing presence in wealth management, expanding asset management operations, and a steadily rising dividend are helping this overlooked financial giant build a compelling long-term income story.

The Dividend Story Emerging from an Unexpected Corner of Tech

A recovering core business, faster-growing new revenue streams, and a larger commitment to shareholder returns are giving this income story a different shape.

This Logistics Giant Is About to Split in Two. Wall Street Thinks Value Could Follow.

A major spin-off, improving margins, and rising analyst confidence are reshaping the outlook for one of the world's biggest transportation companies.

This Consumer Health Story Just Added a Bigger Growth Engine

Trusted brands, improving execution, a yield that already stands out, and a transformational deal on the horizon. This consumer health name looks built for patient income investors.

From Trail Shoes to Momentum: A Familiar Name Finds Its Stride Again